×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
AstraZeneca concludes equity investment in Cellectis
Pharmaceutical Technology
Cellectis SA · AstraZeneca and Nona Biosciences sign agreement for monoclonal antibody · AstraZeneca makes another obesity play funnelling $80m...
2 weeks ago
AstraZeneca invests $140M in Cellectis, raising stake to 44%
MSN
AstraZeneca (NASDAQ:AZN) has completed its previously announced $140M investment in Cellectis (NASDAQ:CLLS), raising its share capital stake in the gene...
3 days ago
AstraZeneca Invests $140M in Cellectis, Secures 44% Stake in CAR-T Specialist
BioSpace
Cell and gene therapy company Cellectis announced Monday it has completed a $140 million investment from AstraZeneca that extends the...
2 weeks ago
CAR T-Cell Therapy for Acute Lymphoblastic Leukemia Market to Register Stunning Growth by 2032, Predicts ...
PR Newswire
The CAR T-cell therapy market for acute lymphoblastic leukemia is poised for substantial growth, driven by the anticipated launch of...
1 day ago
Cellectis Reports Financial Results for the Fourth Quarter and Full Year 2023
GlobeNewswire
Preliminary results of NATHALI-01 and updated results of BALLI-01 Phase I clinical studies presented at the American Society of Hematology...
3 weeks ago
CFOs depart Vir, Cellectis
BioCentury
Vir Biotechnology Inc. (NASDAQ:VIR) and Cellectis S.A. (Euronext:ALCLS; NASDAQ:CLLS) both announced CFO changes.
3 weeks ago
AstraZeneca to invest $245 mln in Cellectis to boost gene therapy prospects
Reuters
AstraZeneca said on Wednesday it would invest $245 million in French biotechnology company Cellectis in a deal aimed at speeding up the...
6 months ago
AstraZeneca takes 22% stake in Cellectis under 10-asset collab
Fierce Biotech
AstraZeneca takes 22% stake in Cellectis as part of collab for 10 cell and gene therapies ... Despite a rethink that saw Cellectis drop its...
6 months ago
Cellectis' open NC plant adds in-house capabilities BioProcess Insider
BioProcess International
Cellectis has opened its clinical and commercial manufacturing facility in Raleigh making it a one-stop-shop company, says firm.
2 months ago
StockNews.com Begins Coverage on Cellectis (NASDAQ:CLLS)
Defense World
Investment analysts at StockNews.com began coverage on shares of Cellectis (NASDAQ:CLLS – Get Free Report) in a research note issued on...
3 days ago